PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:02 AM ET

Sponsor Check › Sponsor group

C

Cerimon

One sponsor team, 3 deal companies · South San Francisco, CA

Grouped because: 1 shared person (automatic match from the filings) · not the same sponsor?

3deal companies
$137.2Mreported sold
52investors
9Form D filings
2009–2025active
0new, last 12 mo
Follow this sponsor groupLook further ↓

Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing in this group Oct 6, 2025 · Courts (RECAP) last checked: Oct 24, 2026, 2:17 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Cerimon is a sponsor group of 3 issuers that PartnerFacts links to one sponsor (shared people; automatic match from the filings), filing 9 Form D filings between Sep 2009 and Oct 2025.

What this means One team, 3 deal companies, about 16 years of track record in SEC filings. We link the companies because the same people or address appear on their forms — tap "Request a correction" if that is wrong.

Combined reported sold: $137.2M to 52 investors (latest filing per issuer). Industries as reported: Pharmaceuticals (1), Biotechnology (1), "Other" (1). Issuers are based in CA (3).

What this means $137.2M raised across the group, about $2.64M per investor. Amounts come from each company's latest Form D; they are what the sponsor reported, not audited figures.

Principal people: Gary Patou (3 issuers, executive officer), Adam Rosenthal (1 issuer, executive officer and director), Amrit Nagpal (1 issuer, director), Ansbert Gadicke (1 issuer, director), Beth Seidenberg (1 issuer, director) and 27 more.

What this means The person on the most companies is usually the one running the show; their page lists every deal.

Activity: 0 new offerings in the last 12 months; latest filing Oct 6, 2025.

What this means No new raise filed in the past year.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA), property records (NYC, FL, IL and TX counties) — 7 court cases matching the name listed in Key records below.

What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 9 public filings for Cerimon and found 17 differences, 6 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Cerimon has not run yet — it is joining a line of 4,984 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

7 cases: 6 closed (disposition not in docket feed), 1 judgment

Piramal Pharma Limited v. Blade Therapeutics, Inc. closed
District Court, D. Delaware · No. 1:23-cv-01044 · Filed Sep 25, 2023 · Closed Jun 18, 2024
Role of Blade Therapeutics, Inc.: Defendant · Outcome: Terminated 2024-06-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact company name; court in DE (not the issuer's state)
Carlisle v. F-Star Therapeutics, Inc. closed
District Court, S.D. New York · No. 1:22-cv-06253 · Filed Jul 22, 2022 · Closed Sep 16, 2022 · Nature of suit: 850 Securities/Commodities · Cause: 15:78m(a) Securities Exchange Act
Role of Carlisle v. F-Star Therapeutics, Inc.: Party · Outcome: Terminated 2022-09-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
company name words appear in the caption; court in NY (not the issuer's state)
Wheeler v. F-Star Therapeutics, Inc. closed
District Court, D. Delaware · No. 1:22-cv-00950 · Filed Jul 20, 2022 · Closed Sep 20, 2022 · Nature of suit: 850 Securities/Commodities · Cause: 15:78m(a) Securities Exchange Act
Role of Wheeler v. F-Star Therapeutics, Inc.: Party · Outcome: Terminated 2022-09-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
company name words appear in the caption; court in DE (not the issuer's state)
Johnson v. F-Star Therapeutics, Inc. closed
District Court, S.D. New York · No. 1:22-cv-06103 · Filed Jul 18, 2022 · Closed Oct 31, 2022
Role of Johnson v. F-Star Therapeutics, Inc.: Party · Outcome: Terminated 2022-10-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
company name words appear in the caption; court in NY (not the issuer's state)
Diebolt v. F-Star Therapeutics, Inc. closed
District Court, S.D. New York · No. 1:22-cv-05941 · Filed Jul 12, 2022 · Closed May 3, 2023 · Nature of suit: 850 Securities/Commodities · Cause: 15:78m(a) Securities Exchange Act
Role of Diebolt v. F-Star Therapeutics, Inc.: Party · Outcome: Terminated 2023-05-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
company name words appear in the caption; court in NY (not the issuer's state)
PPD Development, LP v. Cerimon Pharmaceuticals, Inc. closed
District Court, N.D. California · No. 3:11-mc-80137 · Filed Jun 14, 2011 · Closed Jun 16, 2011
Role of Cerimon Pharmaceuticals, Inc.: Defendant · Outcome: Terminated 2011-06-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact company name; court in the issuer's state (CA)
PPD Development, LP v. Cerimon Pharmaceuticals, Inc judgment
District Court, E.D. North Carolina · No. 7:10-cv-00166 · Filed Aug 26, 2010 · Closed Nov 9, 2010 · Nature of suit: 190 Other contract actions
Role of Cerimon Pharmaceuticals, Inc: Defendant · Outcome: Terminated 2010-11-09 — FJC Integrated Database disposition: Judgment on consent; judgment for plaintiff Docket on CourtListener ↗
exact company name; court in NC (not the issuer's state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:17 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Cerimon..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

No comparisons published

What is compared

No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.

17 differences found between the filings for Cerimon — 6 worth asking about (compared 9 filings on Oct 24, 2026)

Worth asking · Jun 24, 2010 – Nov 15, 2010

Amount sold went down between filings — Cerimon Pharmaceuticals, Inc.

The Jun 24, 2010 filing says $1,000,000 sold; the Nov 15, 2010 Form D/A says $232,957 sold — $767,043 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D/A (earlier) · Jun 24, 2010 ↗Form D/A (later) · Nov 15, 2010 ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Sep 9, 2009 – Apr 2, 2010

Amount sold went down between filings — Cerimon Pharmaceuticals, Inc.

The Sep 9, 2009 filing says $1,500,003 sold; the Apr 2, 2010 Form D says $750,000 sold — $750,003 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Sep 9, 2009 ↗Form D (later) · Apr 2, 2010 ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jun 24, 2010 – Nov 15, 2010

Investor count went down between filings — Cerimon Pharmaceuticals, Inc.

The Jun 24, 2010 filing reports 10 investors; the Nov 15, 2010 Form D/A reports 9 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Jun 24, 2010 ↗Form D/A (later) · Nov 15, 2010 ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Nov 8, 2018 – Oct 24, 2019

Form D filed 350 days after the first sale — Blade Therapeutics, Inc.

The filing says the first sale was Nov 8, 2018. The Form D was filed Oct 24, 2019 — 350 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 335 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Form D · Oct 24, 2019 ↗Blade Therapeutics, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jun 24, 2010 – Nov 15, 2010

James H. Welch is no longer listed on the Nov 15, 2010 amendment — Cerimon Pharmaceuticals, Inc.

James H. Welch appears on the Jun 24, 2010 Form D/A (executive officer) but not on the Nov 15, 2010 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D/A · Jun 24, 2010 ↗Form D/A · Nov 15, 2010 ↗James H. Welch — PartnerFacts page ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Sep 9, 2009 – Jun 24, 2010

Robert Adelman is no longer listed on the Jun 24, 2010 amendment — Cerimon Pharmaceuticals, Inc.

Robert Adelman appears on the Sep 9, 2009 Form D (director) but not on the Jun 24, 2010 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D · Sep 9, 2009 ↗Form D/A · Jun 24, 2010 ↗Robert Adelman — PartnerFacts page ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Sep 23, 2019 – Oct 24, 2019

Form D filed 31 days after the first sale — Blade Therapeutics, Inc.

The filing says the first sale was Sep 23, 2019. The Form D was filed Oct 24, 2019 — 31 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 16 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Oct 24, 2019 ↗Blade Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 2, 2010 – Jun 24, 2010

James S. Shannon's role changed at Cerimon Pharmaceuticals, Inc.: executive officer, director → director

The Apr 2, 2010 filing lists James S. Shannon as executive officer, director; the Jun 24, 2010 Form D/A lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Apr 2, 2010 ↗Form D/A · Jun 24, 2010 ↗James S. Shannon — PartnerFacts page ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jun 24, 2010 – Nov 15, 2010

Offering amount lowered between filings — Cerimon Pharmaceuticals, Inc.

The Jun 24, 2010 filing says $1,000,000 offered; the Nov 15, 2010 Form D/A says $250,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D/A (earlier) · Jun 24, 2010 ↗Form D/A (later) · Nov 15, 2010 ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Apr 2, 2010 – Jun 24, 2010

Offering amount changed between filings — Cerimon Pharmaceuticals, Inc.

The Apr 2, 2010 filing says $750,000 offered; the Jun 24, 2010 Form D/A says $1,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Apr 2, 2010 ↗Form D/A (later) · Jun 24, 2010 ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Sep 9, 2009 – Apr 2, 2010

Offering amount lowered between filings — Cerimon Pharmaceuticals, Inc.

The Sep 9, 2009 filing says $1,500,003 offered; the Apr 2, 2010 Form D says $750,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Sep 9, 2009 ↗Form D (later) · Apr 2, 2010 ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Sep 2, 2009 – Oct 24, 2019

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Blade Therapeutics, Inc. (latest filing Oct 24, 2019) · No amendment in the last 12 months on an offering that may still be open — Blade Therapeutics, Inc. (latest filing Oct 24, 2019) · No amendment in the last 12 months on an offering that may still be open — Blade Therapeutics, Inc. (latest filing Jun 20, 2016) · No amendment in the last 12 months on an offering that may still be open — Cerimon Pharmaceuticals, Inc. (latest filing Nov 15, 2010)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Oct 24, 2019 ↗Blade Therapeutics, Inc. — PartnerFacts page ↗Form D · Oct 24, 2019 ↗Form D · Jun 20, 2016 ↗
Sources
Note · Jun 20, 2016 – Oct 24, 2019

Wendye Robbins is written 2 different ways on the filings

listed as "Wendye Robbins" on the Jun 20, 2016 filing, and "Wendye Rae Robbins" on 2 filings (from Oct 24, 2019).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jun 20, 2016 ↗Form D · Oct 24, 2019 ↗Wendye Robbins — PartnerFacts page ↗
Sources
Note · Jun 20, 2016 – Oct 24, 2019

William V. Slattery is written 2 different ways on the filings

listed as "William Slattery" on the Jun 20, 2016 filing, and "William V. Slattery" on 2 filings (from Oct 24, 2019).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jun 20, 2016 ↗Form D · Oct 24, 2019 ↗William V. Slattery — PartnerFacts page ↗
Sources
Note · Sep 9, 2009 – Nov 15, 2010

James S. Shannon is written 2 different ways on the filings

listed as "James S. Shannon" on 3 filings (from Sep 9, 2009), and "James Shannon" on 2 filings (from Nov 15, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Sep 9, 2009 ↗Form D/A · Nov 15, 2010 ↗James S. Shannon — PartnerFacts page ↗
Sources
Note · Jun 20, 2016 – Oct 24, 2019

Issuer used a different name before — Blade Therapeutics, Inc.

SEC records list prior names for this filer: FibroRX, Inc.. The current name on file is "Blade Therapeutics, Inc.".

What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.

EDGAR filer page ↗Blade Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Sep 9, 2009 – Nov 15, 2010

Issuer used a different name before — Cerimon Pharmaceuticals, Inc.

SEC records list prior names for this filer: Costes Pharmaceuticals, Inc.; Cerimon Pharmaceuticals Inc. The current name on file is "Cerimon Pharmaceuticals, Inc.".

What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.

EDGAR filer page ↗Cerimon Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 5 offerings report sales commissions; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 6, 2025 D
Star Therapeutics LLC
File 021-559890
$0$0$0None listed on this filingEDGAR ↗
Oct 24, 2019 D
Blade Therapeutics, Inc.
File 021-351771
$0$0$0N/A no CRD number reportedEDGAR ↗
Oct 24, 2019 D
Blade Therapeutics, Inc.
File 021-351778
$0$0$0N/A no CRD number reportedEDGAR ↗
Jun 20, 2016 D
Blade Therapeutics, Inc.
File 021-265375
$0$0$0None listed on this filingEDGAR ↗
Nov 15, 2010 D/A
Cerimon Pharmaceuticals, Inc.
File 021-77816
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across all 3 issuers in this group — every filing in our index, latest filing per offering (SEC file number).

Property records 0 documents · 0 ownership records · last checked Oct 23, 2026, 8:59 PM ET · NYC and Cook County lookup still to run

0 recorded documents and 0 ownership records matched to Cerimon in the sources searched.

Not found in sources searched as of Oct 23, 2026, 8:59 PM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET; Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Still to be looked up for this group: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.

Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed); Harris County TX and Dallas County TX (assessor ownership rolls only, 2026 roll; no deed, mortgage or sale records); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not covered). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Dade 23) Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Hillsborough 39) Oct 23, 2026, 8:54 PM ET. NYC and Cook County are looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.

Issuers in this group

Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.

SourceIssuerLinked byLocationIndustryFilingsSold (max)InvestorsMin. investment (latest filing)Active
EDGAR ↗CP Cerimon Pharmaceuticals, Inc.shared peopleSOUTH SAN FRANCISCO, CAPharmaceuticals5$1,500,00310No minimum reported2009–2010
EDGAR ↗BT Blade Therapeutics, Inc.shared peopleSouth San Francisco, CABiotechnology3$37,999,992
offering $23,960,737 · similar: $2,000,000–$19,999,994
21
similar: 2–16
No minimum reported
similar: $10,000–$50,000
2016–2019
EDGAR ↗ST Star Therapeutics LLCshared peopleSOUTH SAN FRANCISCO, CAOther1$124,999,974
offering $124,999,974 · similar: $500,000–$7,000,000
21
similar: 2–14
No minimum reported
similar: $5,000–$50,000
2025–2025

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Timeline of offerings

SourceFiledIssuerFormIndustryOfferedSold
EDGAR ↗Oct 6, 2025Star Therapeutics LLCDOther$124,999,974$124,999,974
EDGAR ↗Oct 24, 2019Blade Therapeutics, Inc.DBiotechnology$23,960,737$11,980,376
EDGAR ↗Oct 24, 2019Blade Therapeutics, Inc.DBiotechnology$49,999,999$37,999,992
EDGAR ↗Jun 20, 2016Blade Therapeutics, Inc.DBiotechnology$45,365,000$27,069,454
EDGAR ↗Nov 15, 2010Cerimon Pharmaceuticals, Inc.D/APharmaceuticals$250,000$232,957
EDGAR ↗Nov 15, 2010Cerimon Pharmaceuticals, Inc.D/APharmaceuticals$250,000$232,957
EDGAR ↗Jun 24, 2010Cerimon Pharmaceuticals, Inc.D/APharmaceuticals$1,000,000$1,000,000
EDGAR ↗Apr 2, 2010Cerimon Pharmaceuticals, Inc.DPharmaceuticals$750,000$750,000
EDGAR ↗Sep 9, 2009Cerimon Pharmaceuticals, Inc.DPharmaceuticals$1,500,003$1,500,003

Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Oct 6, 2025. Industry history, as reported on each offering's latest filing: Previous offerings: Pharmaceuticals (2009), Biotechnology (2016–2019). Latest offering: Other (Oct 6, 2025).

People across the group

NameRolesIssuers hereFirst → last listed
GP Gary PatouExecutive Officer3Jun 24, 2010 → Oct 6, 2025
CG Carl L. GordonDirector1Oct 6, 2025 → Oct 6, 2025
MF Matthew FustDirector1Oct 6, 2025 → Oct 6, 2025
NS Nancy StaglianoDirector1Oct 6, 2025 → Oct 6, 2025
MC Michelle CarpenterExecutive Officer1Oct 6, 2025 → Oct 6, 2025
AN Amrit NagpalDirector1Oct 6, 2025 → Oct 6, 2025
BS Beth SeidenbergDirector1Oct 6, 2025 → Oct 6, 2025
SP Sandip PanickerExecutive Officer1Oct 6, 2025 → Oct 6, 2025
SR Scott RobertsonExecutive Officer1Oct 6, 2025 → Oct 6, 2025
AR Adam RosenthalExecutive Officer, Director1Oct 6, 2025 → Oct 6, 2025
MK Maha KatabiDirector1Oct 6, 2025 → Oct 6, 2025
JH Jason HaflerDirector1Oct 6, 2025 → Oct 6, 2025
RH Rana Al-HallaqDirector1Oct 24, 2019 → Oct 24, 2019
LE Luke EvninDirector1Jun 20, 2016 → Oct 24, 2019
WR Wendye RobbinsExecutive Officer, Director1Jun 20, 2016 → Oct 24, 2019
JS James ScopaDirector1Jun 20, 2016 → Oct 24, 2019
PV Peter Van VlasselaerDirector1Jun 20, 2016 → Oct 24, 2019
WS William V. SlatteryDirector1Jun 20, 2016 → Oct 24, 2019
CW Cameron WheelerDirector1Jun 20, 2016 → Oct 24, 2019
PI Prabha IbrahimExecutive Officer1Oct 24, 2019 → Oct 24, 2019
LK Lloyd B. KlicksteinDirector1Oct 24, 2019 → Oct 24, 2019
MC M. Shirley ChiangExecutive Officer1Oct 24, 2019 → Oct 24, 2019
EJ Elaine JonesDirector1Jun 20, 2016 → Jun 20, 2016
AG Ansbert GadickeDirector1Sep 9, 2009 → Nov 15, 2010
DK Denise Pollard-KnightDirector1Sep 9, 2009 → Nov 15, 2010
JS James S. ShannonExecutive Officer, Director1Sep 9, 2009 → Nov 15, 2010
MM Matthew J. MeyerExecutive Officer1Sep 9, 2009 → Nov 15, 2010
PH Paul HastingsDirector1Sep 9, 2009 → Nov 15, 2010
VK Vaughn KailianDirector1Sep 9, 2009 → Nov 15, 2010
SW Samuel P. WertheimerDirector1Apr 2, 2010 → Nov 15, 2010
JW James H. WelchExecutive Officer1Sep 9, 2009 → Jun 24, 2010
RA Robert AdelmanDirector1Sep 9, 2009 → Sep 9, 2009

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Cerimon.

Meta advertising

No Meta Pixel ids or Facebook / Instagram page links on file for Cerimon as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Public profiles and social

No website or social profile named in Cerimon's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #59,131 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Export this report as PDF · Premium

Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".

Change history

No corrections have been requested for this page.

Request a correction

Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.

Sponsor response

Add a sourced explanation next to any fact. Reviewed before publishing.

Grouping is PartnerFacts' inference from public filings (shared related persons, management entities, business address). Everything else on this page is drawn from the filings themselves. Not the same sponsor? Request a correction.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (outside the US (as filed: SOUTH SAN FRANCISCO), CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn companies ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗OpenCorporates ↗